Efalizumab-induced severe thrombocytopenia can be resolved
Francesca Prignano, F Zanieri, S Mokhtarzadeh, T LottiUniversity Unit of Dermatology and Physiotherapy, School of Medicine, University of Florence, Florence, ItalyAbstract: Efalizumab is a monoclonal a humanized recombinant IgG1 monoclonal antibody which targets the CD11a, the alpha-subunit of LFA-1...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-11-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/efalizumab-induced-severe-thrombocytopenia-can-be-resolved-a2546 |